NCT04781036 (Foot-skin M&M) is a NA clinical trial of 4%Chlorhexidine in Microbial Disease, sponsored by Mahidol University.

Who is sponsoring NCT04781036?

NCT04781036 is sponsored by Mahidol University.

What drugs are being tested in NCT04781036?

Interventions in NCT04781036: 4%Chlorhexidine.

What condition does NCT04781036 study?

NCT04781036 studies Microbial Disease, Metabolomics.

Is NCT04781036 still recruiting?

NCT04781036 is currently status unknown. Last updated 18 March 2024.

Last reviewed 2024-03-18 · How we verify

NCT04781036: Foot-skin M&M

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Foot-skin Microbiome and Metabolomics of Pitted Keratolysis

Status unknown NA Last updated 18 March 2024

What this trial tests

NA trial testing 4%Chlorhexidine in Microbial Disease in 250 participants. Status unknown.

Timeline

1 May 2023

Primary endpoint
1 December 2024

1 December 2024

Quick facts

Lead sponsor	Mahidol University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	basic science
Enrollment	250
Start date	1 May 2023
Primary completion	1 December 2024
Estimated completion	1 December 2024
Sites	2 locations across Thailand

Drugs / interventions tested

4%Chlorhexidine — full drug profile →

Conditions studied

Microbial Disease — all drugs for Microbial Disease →
Metabolomics — all drugs for Metabolomics →

Sponsor

Mahidol University

Who can join

18 and older, male only, with Microbial Disease or Metabolomics. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to investigate the skin microbiome and metabolomics of patients with pitted keratolysis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Microbial Disease

Currently open trials in the same condition.

NCT03962920 — Personalized Treatment of Urogenital Cancers Depends on the Microbiome · NA · recruiting

Other Mahidol University trials

Trials by the same sponsor.

NCT07568496 — Greater Occipital Nerve Block for Migraine With Medication Overuse Headache · NA · not yet recruiting
NCT07407400 — Lemborexant for Sleep and Delirium Prevention in Elderly ICU Patients · Phase 4 · not yet recruiting
NCT07378501 — Thai Version of the Pediatric Quality of Recovery Score (PedSQoR): Translation and Psychometric Validation Study · not yet recruiting
NCT07438301 — Septic Shock Hemodynamic Respond to Volume Resuscitation Versus Vasopressor Administration · not yet recruiting
NCT07390006 — Enabling Patient-Reported Outcomes Through Innovative Care - ACS (EPIC-ACS) · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04781036 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mahidol University
Last refreshed: 18 March 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04781036.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing